Incidence of hypocalcemia in pediatric patients with Down syndrome: a prospective observational study
DOI:
https://doi.org/10.18203/2349-3291.ijcp20260085Keywords:
Downs syndrome, Hypocalcemia, Hypoparathyroidism, Vitamin D deficiency, Pediatric endocrinologyAbstract
Background: Down syndrome (DS) is the most frequently occurring chromosomal condition, affecting from 1 in 700 to 1 in 1,500 live-born babies. Children with DS are at high risk of developing metabolic and endocrine abnormalities such as thyroid dysfunction, diabetes mellitus, obesity, short stature, vitamin D deficiency, low bone mineral density, and gonadal dysfunction than the general population. However, the prevalence and persistence of hypocalcemia in early childhood remain underexplored. This study aimed to assess the incidence and significance of hypocalcemia in pediatric patients with DS aged 1 to 5 years.
Methods: A prospective observational study was conducted on 55 children with genetically confirmed DS, aged 1 to 5 years. Serum calcium, phosphate, and parathyroid hormone (PTH) levels were measured at baseline and followed up for over 12 months. Vitamin D levels and dietary calcium intake were also assessed. Statistical analysis was performed to compare hypocalcemia prevalence with general pediatric population data.
Results: Hypocalcemia (serum calcium <8.5 mg/dl) was observed in 21 out of 55 children (38.2%), which was significantly higher than in the general pediatric population (p<0.001). Hypoparathyroidism was identified in 11 cases (20%), with persistently low PTH levels. Vitamin D deficiency was present in 27 children (49%), contributing to secondary hypocalcemia in some cases. Clinical symptoms: Hypotonia (35%), delayed motor milestones (22%), and seizures (7%).
Conclusions: Hypocalcemia is significantly more prevalent in children with DS aged 1 to 5 years, with hypoparathyroidism and vitamin D deficiency being major contributing factors. Routine screening and early calcium and vitamin D supplementation may help prevent complications in this vulnerable population.
Metrics
References
de Graaf G, Buckley F, Skotko BG. Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United States. Am J Med Genet A. 2015;167A(4):756-67. DOI: https://doi.org/10.1002/ajmg.a.37001
Parker SE, Mai CT, Canfield MA. Updated National Birth Prevalence Estimates for Selected Birth Defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008-16. DOI: https://doi.org/10.1002/bdra.20735
Bull MJ. Health supervision for children with Down syndrome. Pediatrics. 2020;145(2):e20193727.
Unachak K, Thongkum J. Thyroid disorders in children with Down syndrome. J Med Assoc Thai. 2017;100(7):738-44.
Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Vitamin D deficiency in children and its management. Pediatrics. 2008;122(2):398-417. DOI: https://doi.org/10.1542/peds.2007-1894
Guaraldi F, Rossetto Giaccherino R, Ghizzoni L. Endocrine disorders in Down syndrome. Pediatr Endocrinol Rev. 2017;14(2):354-62.
Parker DR, O’Leary P, Telford M. Parathyroid hormone levels and calcium metabolism in Down syndrome. Clin Endocrinol (Oxf). 2010;73(1):12-8.
Roizen NJ, Patterson D. Down’s syndrome. Lancet. 2003;361(9365):1281-9. DOI: https://doi.org/10.1016/S0140-6736(03)12987-X
Feigerlova E, Kelly A. Hypocalcemia in children: clinical features and etiologies. Eur J Endocrinol. 2019;181(4):R175-92.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81. DOI: https://doi.org/10.1056/NEJMra070553
Santos J, Mazepa M, Prigol A. Vitamin D deficiency in children with Down syndrome. J Pediatr (Rio J). 2018;94(6):630-6.
Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S-6S. DOI: https://doi.org/10.1093/ajcn/87.4.1080S
Downloads
Published
How to Cite
Issue
Section
